Figure 3From: Hypofractionated radiotherapy for primary or secondary oligometastatic lung cancer using TomotherapyOverall survival difference of 2 and 3 total oligometastatic lesions in all 33 patients. Median survival were undefined and 26 months separately (p = 0.065).Back to article page